Clinical outcomes and lung toxicities after lung SABR using dynamic conformal arc therapy: a single-institution cohort study

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is a validated treatment for early stage lung cancer and pulmonary metastases. It provides a high local control rate with low symptomatic toxicities. Recently, Dynamic Conformal Arc Therapy (DCAT), a delivery option that differs from conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Mesny, Emmanuel, Ayadi, Myriam, Dupuis, Pauline, Beldjoudi, Guillaume, Tanguy, Ronan, Martel-Lafay, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948312/
https://www.ncbi.nlm.nih.gov/pubmed/36814265
http://dx.doi.org/10.1186/s13014-023-02227-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948312/
https://www.ncbi.nlm.nih.gov/pubmed/36814265
http://dx.doi.org/10.1186/s13014-023-02227-2

Ejemplares similares